Clinical Trials Browser

Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Gastrointestinal Neoplasms, Colorectal Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Neoplasm Metastasis, Stomach Neoplasms

Biliary Tract Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Colorectal Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Gastroesophageal Adenocarcinoma

Rectal Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Solid Tumors

Locally Advanced Colorectal Carcinoma

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Gastroesophageal Junction Adenocarcinoma

Carcinoma, Hepatocellular

Stomach Neoplasms

Rectal Neoplasms

Advanced Solid Tumors

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Beacon-BTC

CIME

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

FOBEAR

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

CAPRI-3 GOIM

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

GRACIE

SEVILLA

Folfox+Irinotecan+Chemort In Esophageal Cancer

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

BIG

PANTHER

A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies

ICT-HCC

Hypo-OPRA

COSENSE-1